Brigham and Women's Hospital (BWH) is the recipient of two 7-year grants from the National Institutes of Health to fund the AIDS Clinical Trial Group (ACTG) Network, resulting in $140 million of total funding. The grants support the ACTG's Leadership and Operations Center and Laboratory Center.

The ACTG has been instrumental in testing therapeutic interventions in HIV-positive patients, resulting in strategies and techniques to treat HIV-associated co-infections and co-morbidities. The ACTG has also established how best to manage HIV and establish treatment guidelines.

Read more from